Euglena Co., Ltd. Share Price

Equities

2931

JP3944370000

Food Processing

Market Closed - Japan Exchange 11:30:00 26/04/2024 am IST 5-day change 1st Jan Change
524 JPY +3.15% Intraday chart for Euglena Co., Ltd. +2.75% -24.82%

Financials

Sales 2022 44.39B 280M 23.37B Sales 2023 46.48B 293M 24.47B Capitalization 81.64B 515M 42.98B
Net income 2022 -2.67B -16.87M -1.41B Net income 2023 -2.65B -16.74M -1.4B EV / Sales 2022 2.77 x
Net Debt 2022 12.27B 77.44M 6.46B Net Debt 2023 9.28B 58.58M 4.89B EV / Sales 2023 1.96 x
P/E ratio 2022
-41.1 x
P/E ratio 2023
-30.6 x
Employees 846
Yield 2022 *
-
Yield 2023
-
Free-Float 69.95%
More Fundamentals * Assessed data
Dynamic Chart
Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million. CI
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut MT
Euglena Slightly Narrows 2023 Attributable Loss as Net Sales Grow MT
Zenhoren Co.,Ltd. agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. for ¥360 million. CI
KAICO, Ltd. announced that it has received ¥810 million in funding from a group of investors CI
Euglena Co., Ltd. agreed to acquire Saticine Medical Co., Ltd. CI
Euglena Co., Ltd. agreed to acquire Japan Beautech Co., Ltd. from Kirei Sozo Holdings, K.K. CI
Euglena Co., Ltd. entered into stock transfer agreement to acquire Nayuta Co., Ltd. from Kirei Sozo Holdings, K.K. and Hiroji Yamazaki for ¥0.0 million. CI
Euglena Widens Attributable Loss in Nine Month MT
Japanese Shares Extend Gains for Sixth Straight Trading Session; Euglena Rises 3% MT
Euglena Opens Call for Chief Future Officers Under 18 Years Old MT
Euglena Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Euglena Sees Attributable Loss Fall in FY22 MT
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023 CI
Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc. CI
More news
1 day+3.15%
1 week+2.75%
Current month-13.53%
1 month-14.80%
3 months-23.28%
6 months-27.52%
Current year-24.82%
More quotes
1 week
500.00
Extreme 500
527.00
1 month
500.00
Extreme 500
620.00
Current year
500.00
Extreme 500
720.00
1 year
500.00
Extreme 500
928.00
3 years
500.00
Extreme 500
1 108.00
5 years
498.00
Extreme 498
1 295.00
10 years
498.00
Extreme 498
2 177.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 01/08/01
Founder 48 09/05/09
Founder 44 09/05/09
Members of the board TitleAgeSince
Director/Board Member 41 -
Founder 44 09/05/09
Founder 44 09/05/09
More insiders
Date Price Change Volume
26/24/26 524 +3.15% 986,900
25/24/25 508 +0.20% 535,300
24/24/24 507 -1.55% 768,500
23/24/23 515 +1.98% 1,302,000
22/24/22 505 -0.98% 975,100

Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST

More quotes
euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
524 JPY
Average target price
1,000 JPY
Spread / Average Target
+90.84%
Consensus